
-
2025 summer was Spain's warmest on record: weather agency
-
Gout of this world? Australian teen sprinter set for first real test
-
Smoke-dried bodies could be world's 'oldest mummies': study
-
Afghan gets life in prison for jihadist knife murder in Germany
-
Trump bringing $15 bn lawsuit against New York Times
-
Juan Mata moves to Melbourne from Australian rivals
-
UN investigators say Israel committing 'genocide' in Gaza
-
Israel bombards Gaza City as UN probe accuses it of 'genocide'
-
Rubio asks Qatar to stay as mediator after Israel strike
-
Drug cheats put India Olympic bid and careers at risk
-
East Timor police fire tear gas on second day of car purchase protests
-
Austria hit with fresh spy claims after govt promises law change
-
Floods devastate India's breadbasket of Punjab
-
In mega-city Lagos, 20 million count on just 100 ambulances
-
FBI chief Kash Patel faces Senate panel
-
Trump says bringing $15 bn lawsuit against New York Times
-
Israel sets Gaza 'on fire' as Rubio warns days left for deal
-
Phillies clinch first MLB division by beating Dodgers
-
'Nothing here': Lack of jobs forces young Nepalis abroad
-
Rubio asks Qatar to stay as mediator after Israeli strike
-
Trump set for unprecedented second UK state visit
-
Lower US tariffs on Japan autos kick in
-
Revamped Bayern face early test as Chelsea come to town
-
Papua New Guinea, Australia to vow mutual defence in new treaty
-
Malawi election a battle of two presidents
-
Asian markets rise as traders prepare for expected US rate cut
-
Malawi votes in a rematch between two presidents as economic crisis bites
-
Australia says social media ban will not age test all users
-
Poland's Nawrocki talks drone defence in Paris and Berlin
-
Trump's fossil fuel agenda challenged in youth climate suit
-
PSG fear impact of injuries as they put Champions League title on the line
-
US Senate confirms Trump aide to Fed as politics loom over rate meeting
-
Papua New Guinea, Australia will commit to mutual defence
-
Trash, mulch and security: All jobs for troops in Washington
-
DEEP Robotics Leads the Industrial Robot Dog Race, Demonstrating Strong Capabilities from Power Grid Inspection to Plateau Scientific Exploration
-
Why Leaders Across Industries Are Trusting and Building Good Driver Mutuality
-
Tocvan Announces Commencement Of Field Work And Airborne Magnetics Survey At Gran Pilar Gold Silver Project; Drilling And Trenching Prep Accelerate Discovery & Pilot Mine Production
-
NFL legend Brady to play in March flag football event at Riyadh
-
Lower US tariffs on Japan autos to take effect Tuesday
-
US strikes second alleged Venezuelan drug boat as tensions mount
-
Protesting Peru residents block trains to Machu Picchu
-
US strikes another alleged Venezuelan drug boat as tensions rise
-
White House vows to take on left-wing 'terror' movement after Kirk killing
-
Brazil's Amazon lost area the size of Spain in 40 years: study
-
US Senate poised to advance Trump aide's appointment at Fed
-
Sri Lanka survive Hong Kong scare for four wicket Asia Cup win
-
Arab, Muslim leaders urge review of Israel ties after Qatar attack
-
Mbappe 'not anxious' over Champions League goal as Bellingham returns
-
Huge pot of Nigerian jollof rice sets Guinness record
-
Heartbreak will help Arsenal's Champions League charge: Arteta

Science of sleep: Why a good night's rest gets harder with age
It's well known that getting a good night's sleep becomes more difficult as we age, but the underlying biology for why this happens has remained poorly understood.
A team of US scientists has now identified how the brain circuitry involved in regulating sleepfulness and wakefulness degrades over time in mice, which they say paves the way for better medicines in humans.
"More than half of people 65 and older complain about the quality of sleep," Stanford University professor Luis de Lecea, who co-authored a study about the finding published Thursday in Science, told AFP.
Research has shown that sleep deprivation is linked to an increased risk of multiple poor health outcomes, from hypertension to heart attacks, diabetes, depression and a build up of brain plaque linked to Alzheimer's.
Insomnia is often treated with a class of drugs known as hypnotics, which include Ambien, but these don't work very well in the elderly population.
For the new study, de Lecea and colleagues decided to investigate hypocretins, key brain chemicals that are generated only by a small cluster of neurons in the brain's hypothalamus, a region located between the eyes and ears.
Of the billions of neurons in the brain, only around 50,000 produce hypocretins.
In 1998, de Lecea and other scientists discovered that hypocretins transmit signals that play a vital role in stabilizing wakefulness.
Since many species experience fragmented sleep as they grow old, it's hypothesized that the same mechanisms are at play across mammals, and prior research had shown degradation of hypocretins leads to narcolepsy in humans, dogs and mice.
The team selected young (three to five months) and old mice (18 to 22 months) and used light carried by fibers to stimulate specific neurons. They recorded the results using imaging techniques.
What they found was that the older mice had lost approximately 38 percent of hypocretins compared to younger mice.
They also discovered that the hypocretins that remained in the older mice were more excitable and easily triggered, making the animals more prone to waking up.
This might be because of the deterioration over time of "potassium channels," which are biological on-off switches critical to the functions of many types of cells.
"The neurons tend to be more active and fire more, and if they fire more, you wake up more frequently," said de Lecea.
Identifying the specific pathway responsible for sleep loss could lead to better drugs, argued Laura Jacobson and Daniel Hoyer, of Australia's Florey Institute of Neuroscience and Mental Health, in a related commentary article.
Current treatments, such as hypnotics, "can induce cognitive complaints and falls," and medicines that target the specific channel might work better, they said.
These will need to be tested in clinical trials -- but an existing drug known as retigabine, which is currently used to treat epilepsy and which targets a similar pathway -- could be promising, said de Lecea.
M.A.Colin--AMWN